Cyclacel Pharmaceuticals Inc (CYCC) Spikes On Tang Capital Stake

Tang Capital Partners LP has taken a nearly 10% stake in Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

Aug 22, 2016 at 11:15 AM
facebook twitter linkedin

After being halted earlier, Cyclacel Pharmaceuticals Inc (CYCC) was last seen up 36% at $9.50. Boosting the biotech stock is a recent Securities and Exchange Commission (SEC) filing which showed Tang Capital Partners LP took a 9.6% stake in CYCC -- making it the firm's second-largest shareholder -- and perhaps an M&A-related halo lift from sector peer Medivation Inc (NASDAQ:MDVN).

Regardless, today's bull gap has sent the shares soaring to levels not seen since late November, although the stock appears to be running out of steam near the round $10 mark. Meanwhile, as Wall Street awaits Cyclacel Pharmaceuticals' update on its lead cancer drug for acute myeloid leukemia (AML) -- due out in the fourth quarter -- traders have been upping the bearish ante of late. Although CYCC remains on the short-sale restricted list today following last Friday's swoon, short interest surged 62.2% in the most recent reporting period.

This skepticism toward Cyclacel Pharmaceuticals Inc (CYCC) isn't shared among analysts, though. While the stock has flown under the radar of most analysts, H.C. Wainwright has given the shares a "buy" rating and a $60 price target -- territory not charted since December 2013. Plus, the brokerage firm recently said that if "we crop AML from the picture and only view valuation fundamentally as a function of the other two clinical programs running, Cyclacel still emerges as attractive."

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners